Bone Biologics Corporation
BBLG
$0.7497
$0.05988.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.86% | -19.90% | -66.72% | -47.84% | -59.85% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.25% | -78.29% | -65.69% | -52.45% | 1.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.50% | -- | -- | -- | -43.30% |
| Total Current Assets | 3.31% | -18.30% | -58.11% | -43.40% | -56.00% |
|
|
|||||
| Total Current Assets | 3.31% | -18.30% | -58.11% | -43.40% | -56.00% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.31% | -18.30% | -58.11% | -43.40% | -56.00% |
|
|
|||||
| Total Accounts Payable | 3.41% | -82.76% | -86.27% | -93.59% | 244.18% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -99.00% | 3.48% | -78.19% | -98.94% | -80.73% |
| Total Other Current Liabilities | -99.00% | 3.48% | -78.19% | -98.94% | -80.73% |
| Total Current Liabilities | -54.57% | -76.89% | -85.26% | -95.90% | -67.37% |
|
|
|||||
| Total Current Liabilities | -54.57% | -76.89% | -85.26% | -95.90% | -67.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -54.57% | -76.89% | -85.26% | -95.90% | -67.37% |
|
|
|||||
| Common Stock & APIC | 5.60% | 4.98% | 2.81% | 8.93% | 7.58% |
| Retained Earnings | -5.08% | -5.22% | -6.61% | -8.07% | -12.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 19.86% | -0.02% | -48.90% | 32.55% | -51.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.86% | -0.02% | -48.90% | 32.55% | -51.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.86% | -0.02% | -48.90% | 32.55% | -51.13% |
|
|
|||||